NDC00083-0165-30: POTASSIUM CHLORIDE TABLETS.
The POTASSIUM CHLORIDE TABLETS is a the manufacturer industrial component. Key specifications include special_features: LONG ACTION METHOD:EXTENDED RELEASE, features_provided: ENTERIC COATED, primary_container_type: BOTTLE, therapeutic_equivalent: SLOW-K BY CIBA PHARM, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 600.000 NF UNITS POTASSIUM CHLORIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-008-3398, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | LONG ACTION METHOD:EXTENDED RELEASE |
| features_provided | ENTERIC COATED |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | SLOW-K BY CIBA PHARM |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 600.000 NF UNITS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| NSN | 6505-01-008-3398 |
| THERAPEUTIC EQUIVALENT | SLOW-K BY CIBA PHARM |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| FEATURES PROVIDED | ENTERIC COATED |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | LONG ACTION METHOD:EXTENDED RELEASE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 600.000 NF UNITS POTASSIUM CHLORIDE ACTIVE INGREDIENT |